Farms.com Home   News

Province Selects Nine Businesses For Innovation Growth Program

The Manitoba government has selected nine businesses to receive more than $750,000 through the Innovation Growth Program (IGP), an investment designed to help them develop and commercialize new, innovative products and services.
 
“The Innovation Growth Program provides support to businesses that are pursuing innovation and new opportunities, building on Manitoba’s many economic strengths,” said Economic Development and Training Minister Ralph Eichler. “Investments in these nine companies will also significantly expand their workforces and help grow Manitoba’s economy over the long term.”
 
The second round of recipients of the Innovation Growth Program include:
- All-Net Municipal Solutions;
- Aurora Aerial Inc.;
- Callia Flowers;
- Cerebra Health;
- Elmer’s Manufacturing Ltd.;
- Evotrux Inc.;
- Micro Traffic Inc.;
- Prairie Grain Analyzers; and
- Red River Press.
 
“At Elmer’s, we maintain an explicit focus on innovation,” said Wendy Dyck, controller for Elmer’s Manufacturing. “It is this spirit that wins us praise and enables us to gain market share on the international stage. With the assistance from the IGP, we will be able to improve time to market of our new grain cart design concept to commercialization in order to meet the needs of new customers.”
 
Eichler noted these companies are forecasting the addition of more than 260 new full-time jobs and $90 million of export sales over the next five years. Manitoba’s Innovation Growth Program is cost-shared with recipients, with Manitoba providing up to 50 per cent of total project costs.
 
The Innovation Growth Program was launched in June 2019.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.